Friday, July 10, 2026

Drug profile · INN

elamipretide hydrochloride

elamipretide hydrochloride (FORZINITY) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — elamipretide hydrochloride
US status
approved
Class
Route
SUBCUTANEOUS
Patents
0
Programs
0
Data quality
0.84

Quick answer

elamipretide hydrochloride (FORZINITY) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN elamipretide hydrochloride
Brand FORZINITY
Route SUBCUTANEOUS
Formulation SOLUTION

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is elamipretide hydrochloride?

elamipretide hydrochloride (FORZINITY) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for elamipretide hydrochloride?

FORZINITY is a marketed brand name for elamipretide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of elamipretide hydrochloride?

elamipretide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.